Drilling Down Into Geron Corporation (GERN)

Geron Corporation (GERN) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $2.20, down from yesterday’s close by -2.22%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Geron Corporation (GERN) currently trades with a market capitalization of $373.71 Million. That value represents a market adjusting for revenues that have been falling by -96.81 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of -$16.17 Million over the past twelve months. Generally speaking, earnings are expected to hold steady in coming quarters. Analysts are forecasting earnings of -$0.05 on a per share basis this quarter. Perhaps, that suggests something about why 3.14% of the outstanding share supply is held by institutional investors.

Technical Analysis

Sometimes, we can understand most about a stock by simply looking at how it has been trading. Looking at the stock’s movement on the chart, Geron Corporation recorded a 52-week high of $3.15. It is now trading 0.95% off that level. The stock is trading $2.04 its 50-day moving average by -0.16%. The stock carved out a 52-week low down at $1.74.

In recent action, Geron Corporation (GERN) has made a move of +7.84% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 12.51, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 20.87% with $158.38 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of GERN.

Previous articleVentas, Inc. (VTR): From Top to Bottom
Next articleThe Case for and Against GameStop Corp. (GME)